ArticleClinical and experimental immunology2014

Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection.

N Nazareth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.